Ebb & Flow

Equities - including biotech - put in a good showing in the first month of the fourth quarter, providing an especially upbeat sign given that October is typically the worst month of the year for equities (see "Rock-tober").

But while October was stellar in relative terms -all major stock indexes tracked by BioCentury gained at least 6% - investors should hold their applause in case the rally turns out to be just another dead cat bounce. And while biotech participated in October's rally, its performance paled in comparison to the other major equity indexes. ...